Transcriptional or translational inhibition blocks low dose NMDA-mediated cell death

Neuroreport. 1995 Apr 19;6(6):942-4. doi: 10.1097/00001756-199504190-00029.

Abstract

Glutamate toxicity in nerve cells has been well documented and may play a role in a broad spectrum of neurological and ophthalmic diseases. Recent work in several laboratories has suggested that an apoptotic-like mechanism may be implicated in glutamate toxicity under certain circumstances. We therefore studied the effects of transcriptional and translational inhibition on glutamate-mediated cell death in retinal ganglion cells. We now report that either cycloheximide or actinomycin D can, even when added 2 h after the initial excitotoxic insult, save retinal ganglion cells from low dose glutamate toxicity. However, cycloheximide or actinomycin D are unable to prevent glutamate-mediated death at higher concentrations of excitotoxin. This result indicates that at low doses, the neurotoxic effects of glutamate may develop through an apoptotic-like mechanism.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Cell Death / drug effects*
  • Cells, Cultured
  • Cycloheximide / pharmacology
  • Dactinomycin / pharmacology
  • Excitatory Amino Acid Antagonists / pharmacology
  • Glutamic Acid / toxicity
  • N-Methylaspartate / antagonists & inhibitors
  • N-Methylaspartate / toxicity*
  • Protein Biosynthesis / drug effects*
  • Rats
  • Retinal Ganglion Cells / drug effects
  • Transcription, Genetic / drug effects*

Substances

  • Excitatory Amino Acid Antagonists
  • Dactinomycin
  • Glutamic Acid
  • N-Methylaspartate
  • Cycloheximide